AddThis Feed Button "Frequently Copied, Never Duplicated"

Showing posts with label over prescribing drugs. Show all posts
Showing posts with label over prescribing drugs. Show all posts

Saturday, July 02, 2011

Doctors 'too reliant on prescribing drugs'

UPDATE: 2 July 2011
E-Prescribing Far from Error-Free By Emily P. Walker, Washington Correspondent, MedPage Today
More than 10% of electronic prescriptions contain an error, according to a new study that determined that prescriptions sent electronically are just as likely to contain mistakes as handwritten ones.

E-prescribing has been heralded by health reform experts and policymakers as a way to reduce medication errors, and the federal government is devoting billions to foster it.

Although most evidence suggests enthusiasm for a more paperless medical system is well-founded, new technology can also introduce new potential for medication errors, Karen Nanji, MD, of Massachusetts General Hospital in Boston, wrote in a paper published in the Journal of American Medical Information Association. SOURCE

Posted 3/17/09
While doctors are medicalizing patients at a rapid rate, especially the elderly, new moves to force E-Prescribing may promote a downturn in the quality of health care as it moves more to rationed and tick box care (knee-jerk, cause/effect, lineal thinking).

Is this yet another call to you, my readers, to make stong efforts now to be more active in your own health care?
GPs are medicalising healthy elderly people, professor warns. Elderly people are being turned into patients by GPs blindly following guidelines to hand out pills for high blood pressure and cholesterol, a professor has said.

by Rebecca Smith, Medical Editor, 03 Mar 2009
The ‘paternalistic society’ and medicine by ‘tick box’ has overtaken personal advice, Michael Oliver, emeritus professor of cardiology at Edinburgh University wrote in the British Medical Journal online.

He said many of the drugs including those for high blood pressure and statins for raised cholesterol have side effects which many elderly people find debilitating.

Prof Oilver wrote: “Nowadays few elderly people are allowed to enjoy being healthy. A bureaucratic demand for documentation can lead to overdiagnosis, overtreatment, and unnecessary anxiety. Preventive action may be irrelevant and even harmful in elderly people. More than 30 years ago, in his book Medical Nemesis, Ivan Illich called this trend “the medicalisation of health.”

He said the GP incentives to diagnose and treat patients, known as the Quality and Outcomes Framework, which means a proportion of the practice income is dependent upon hitting target, has meant many elderly people who considered themselves healthy are being put on pills.

Prof Oliver said: “Many older people, often retired, are summoned by their general practitioner for an annual health check. They may feel reasonably well, but the NHS does not always permit such euphoria. They may be told that they have hypertension or diabetes or high cholesterol concentrations; that they are obese; that they take too little exercise, eat unhealthily, and drink too much.”

He warned that the practice of medicalising the elderly can be harmful and many of the guidelines for treating high blood pressure and cholesterol are based on much younger people or on evidence that the drugs reduce the risk of a heart attack or stroke, but only by a small amount.

He added: “Are those people who have now been turned into patients warned sufficiently about side effects? Are minor side effects, which can be debilitating in this age group, reported to health authorities? More importantly, are doctors willing to discontinue treatment and permit these patients to return to their previously unencumbered and reasonably fit lives?”

David Stout, director of the Primary Care Trust Network at the NHS Confederation, said: “It is important to have procedures in place to ensure a high standard of healthcare for all patients, irrespective of their age. However there is no such thing as ‘one size fits all’ when it comes to healthcare. All GPs treat elderly patients on an individual basis and this should remain the case. Guidelines are exactly that and should not be taken as a binding instruction.”

http://www.telegraph.co.uk/health/healthnews/4932032/GPs-are-medicalising-healthy-elderly-people-professor-warns.html

E-prescribing to soar with new spending By Will Dunham, Mon Mar 16, 2009

WASHINGTON (Reuters) – As many as 75 percent of U.S. doctors will be writing electronic prescriptions within five years, thanks to new federal spending to encourage e-prescribing, according to a forecast released on Monday.

The economic stimulus bill signed by President Barack Obama last month included about $19 billion to promote the use of healthcare information technology, including e-prescribing.

"Broader health IT (information technology) adoption will create a safety revolution in American healthcare," Pharmaceutical Care Management Association President and Chief Executive Officer Mark Merritt said in a telephone interview.

An estimated 13 percent of U.S. doctors prescribe drugs electronically, leaving the vast majority writing paper prescriptions, according to Surescripts, which operates the largest U.S. electronic prescribing network.

The report projected the figure would increase to 75 percent in five years and to about 90 percent by 2018.

The report, prepared by the healthcare research firm Visante for PCMA, projected that e-prescribing would save the U.S. government $22 billion over the next decade, more than covering the $19 billion in spending in the stimulus bill.

Among other things, the savings would come from increased use of cheaper generic drugs and the prevention of medical errors such as patients getting the wrong drug because a pharmacy misreads a doctor's handwriting, the report said.

Greater use of e-prescribing also will prevent 3.5 million medication errors and 585,000 hospitalizations by 2018, the report projected.

Seventy-six percent of U.S. retail pharmacies can handle prescriptions electronically.

The advantages of e-prescribing -- sending a prescription electronically to a pharmacy -- are widely recognized, but the costs of adopting it have dissuaded many doctors.

The drive toward greater use of e-prescribing and electronic medical records is part of Obama's plans for a sweeping overhaul of the U.S. healthcare system.

In addition, Medicare, the federal health insurance program for the elderly and disabled, in January began to offer financial bonuses to doctors who use e-prescribing.

(Editing by Maggie Fox and Eric Walsh)
Copyright © 2009 Reuters Limited

Doctors are too reliant on prescribing drugs for heart disease at the expense of helping their patients to lead healthier lives, a new study suggests.

by Kate Devlin, Medical Correspondent, The Telegraph, UK, 12 Mar 2009

Some patients are receiving too little advice about cutting down on smoking or reducing their weight as doctors increasingly reach for pills to treat them, according to the study, published in the Lancet medical journal.

The report comes just a week after a leading expert warned that millions of elderly patients were being prescribed drugs that they did not need, for conditions ranging from high blood pressure to high cholesterol or diabetes.

Professor Michael Oliver warned that a "tick-box culture" was leading to overtreatment and unnecessary anxiety for many older people.

The latest study looked at the treatment of heart disease across 22 European countries.

It found that one in five people diagnosed with the condition continued to smoke, in spite of the well-known problems that smoking can cause for the heart.

Researchers also found that sufferers were twice as likely to have diabetes as 12 years ago, partly because of the growing problem of obesity.

Only around one in three patients surveyed were referred to programmes designed to prevent heart attacks by focusing on lifestyle changes.

At the same time researchers found that doctors were prescribing greater numbers of drugs.

"The results of the study should be a cause for concern for all health policy makers, physicians and other healthcare professionals," according to its authors, led by Professor David Wood from Imperial College London.

Heart disease is Britain's biggest killer and every six minutes someone dies from a heart attack in this country.

Wednesday, January 06, 2010

FDA licenses high-dose flu vaccine for elderly

I just finished having a conversation with an investigative reporter regarding over-drugging of the elderly in care homes.  This followed on Diane Sawyer's news piece last evening on ABC News.

Then I happened to check a message from Dr. Tenpenny about a vaccine targetted to the elderly containing foru times the amount of the reguar flu vaccine dose.  The premise is alleged to be because the elderly have a less active immune system.

Someday I hope that these people who beleive that if you have a vaccine for every ailment you will health the world will wake up to the fact that the germ theory was completely debunked and we need to have a new paradigm.
By Robert Roos, News Editor


Dec 28, 2009 (CIDRAP News) – The US Food and Drug Administration (FDA) has approved a high-dose seasonal influenza vaccine for elderly people, whose aging immune systems may not respond effectively to flu vaccines intended for younger people.

The vaccine, Fluzone High-Dose, made by Sanofi Pasteur, contains four times as much antigen (active ingredient) as standard seasonal flu vaccines. The FDA and the company announced its approval Dec 23.

The vaccine is intended for people aged 65 years and older and will be available in time for the 2010-11 flu season, Sanofi officials said in a press release. It apparently is the first flu vaccine licensed in the United States specifically for older people.

In a large phase 3 trial conducted during the 2006-07 flu season, the vaccine induced significantly stronger immune responses than standard-dose vaccine did. Nonserious side effects were more common with the high-dose vaccine, but the overall safety profile was similar to that of the standard vaccine, the company said. The study did not assess actual protection from flu.

The FDA used its "accelerated approval pathway" to review the vaccine, the company having filed its application in March, according to Michelle Yeboah, an FDA spokeswoman. As part of that process, Sanofi will be required to conduct further studies to determine whether the vaccine decreases flu in recipients, the agency said.

"As people grow older, their immune systems typically become weaker," said Karen Midthun, MD, acting director of the FDA's Center for Biologics Evaluation and Research, in the FDA announcement. "This is the first vaccine that uses a higher dose to induce a stronger immune response that is intended to better protect the elderly against seasonal influenza."

Researchers estimate that elderly people account for about 90% of the deaths related to seasonal flu each year. In contrast, younger and middle-aged adults bear most of the burden of severe cases and deaths related to the pandemic H1N1 virus.
Each dose of Fluzone High-Dose will contain 180 micrograms (mcg) of antigen—60 mcg for each of the three flu strains normally targeted in seasonal vaccines, the FDA said. Standard seasonal flu vaccines contain 15 mcg for each strain, for a total of 45 mcg.

Sanofi Pasteur has been the largest producer of flu vaccine for the US market in recent years. Ellyn Schindler, a company spokeswoman, declined to say today how many doses of the high-dose vaccine might be made for the next season, commenting that production plans are proprietary and will depend in part on customer reservations.

"We have two influenza vaccine production facilities licensed in the U.S. which should provide adequate capacity to produce this vaccine as well as our other formulations of influenza vaccines for the 2010-2011 season," Schindler said.

Sanofi made 50.5 million seasonal vaccine doses this year and is producing 75.3 million doses of pandemic H1N1 vaccine, she noted.

The phase 3 trial of Fluzone High-Dose involved 3,856 elderly people, about two thirds of whom received that vaccine and a third the standard dose of Fluzone, according to Sanofi. A report of the trial was published in the Journal of Infectious Diseases (JID) in July.

Volunteers who received the high-dose vaccine had significantly stronger immune responses than those who received the standard dose. The response to the two influenza A strains (H3N2 and H1N1) in the vaccine met predefined superiority criteria, while the response to the B strain met noninferiority criteria, according to the JID report.

Injection-site reactions were more common in those who received the high-dose vaccine, but they were mild to moderate, the report said. The FDA said the rates of serious adverse events were comparable for the two vaccines.

In an editorial that accompanied the JID report, vaccine experts Gregory A. Poland of the Mayo Clinic and Mark J. Mulligan of Emory University commented, "Overall, the rate of adverse events in the HD [high-dose] vaccine group was acceptable although somewhat increased, as would be anticipated" for high-dose trivalent influenza vaccine (TIV).
Multiple studies now have yielded "uniform evidence of enhanced immunogenicity, acceptable reactogenicity, safety, and some evidence of efficacy for HD TIV influenza vaccines," Poland and Mulligan wrote.

Wednesday, December 23, 2009

Too many Drugs, Too High Doses: Too Much for Elders

My mother was an Elder.  She was over-drugged for a number of years in a Florida Five-Star facility and the threat of forced relocation was held over her POA if she wasn't drugged.  I'm sure Medicare fraud is an issue here but needless to say, she was not alone.

I'm also wondering why doctors can't look at magnesium and B complex before drugs for hypertension, or even other natural approaches.
Old heart patients 'over-drugged'

Elderly patients are being treated too aggressively for high blood pressure, researchers claim.

They say the "oldest olds", meaning patients aged 80 plus, are being given too many drugs and in too large doses, which may do them more harm than good.

The Cochrane scientists who looked at the available data say doctors can set their targets lower for octogenarians.  This makes good economic and clinical sense given the expanding elderly population, they told bmj.com.

But doctors said high blood pressure is largely under-recognised and under-treated in the UK.

Growing need

Experts say the "oldest olds" are the fastest growing sector of the world's population.

According to latest estimates, the UK population of 85-year-olds will go up by a third by 2020.

And more than half of these will need treatment for high blood pressure, the British Medical Journal reports.

“ Most sensible GPs - which most GPs are - take a pretty cautious view to doling out drugs to old people. ”  Professor Peter Weissberg British Heart Foundation
But head of the Cochrane research group, Dr James Wright, says clinicians should change what they are presently doing and move towards a more conservative approach for the over 80s.

"I have done so with my patients," he said.

'Less better'

His review of existing studies, including data from two new trials which looked specifically at the effect of blood pressure drugs in this age group, found little evidence that aggressive treatment saves more lives.

Although fewer patients died of strokes, the total number of deaths from all causes was unchanged.

The only trial that found a significant reduction in overall mortality was the most conservative in terms of number of drugs and dose of drugs allowed.

Based on the findings, he suggests a target blood pressure of 150/80 mmHg is more sensible, and says doctors should not be worried if only half of their most elderly patients achieve it.

Professor Peter Weissberg, of the British Heart Foundation, said: "Most sensible GPs - which most GPs are - take a pretty cautious view to doling out drugs to old people.

"Hypertension is still largely under-treated. By and large, in the UK population, half of people with high blood pressure are not identified."

Story from BBC NEWS: http://news.bbc.co.uk/go/pr/fr/-/2/hi/health/8426199.stm
Published: 2009/12/23 © BBC MMIX